Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors
Autor: | Dominic A.X. Schinagl, Otto Visser, Nicola S. Russell, Jourik A. Gietema, Michael Schaapveld, Naomi B. Boekel, Philip Poortmans, Emiel J. Th. Rutgers, Flora E. van Leeuwen, Berthe M.P. Aleman, Derek H. F. Rietveld, Michel I.M. Versteegh, Jacqueline C.M. Theuws |
---|---|
Přispěvatelé: | Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Radiation Oncology, CCA - Clinical Therapy Development, Epidemiology and Data Science, EMGO - Quality of care |
Rok vydání: | 2016 |
Předmět: |
Cancer Research
Time Factors Heart disease Heart Valve Diseases Myocardial Ischemia CHILDHOOD 030204 cardiovascular system & hematology Cohort Studies 0302 clinical medicine Cause of Death Antineoplastic Combined Chemotherapy Protocols FAILURE Registries Survivors Mastectomy Netherlands Cause of death education.field_of_study Radiation LONG-TERM SURVIVORS valvular heart disease Age Factors WOMEN Heart Middle Aged CHEMOTHERAPY Combined Modality Therapy Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] Oncology Cardiovascular Diseases Chemotherapy Adjuvant 030220 oncology & carcinogenesis Cohort Female Fluorouracil RADIOTHERAPY Cohort study medicine.medical_specialty Population Antineoplastic Agents HEART-DISEASE Risk Assessment 03 medical and health sciences LUNG-CANCER Breast cancer Internal medicine Confidence Intervals Unilateral Breast Neoplasms medicine Humans Radiology Nuclear Medicine and imaging cardiovascular diseases education Aged Heart Failure Lymphatic Irradiation business.industry CAUSE-SPECIFIC MORTALITY ANTHRACYCLINE medicine.disease Surgery Carcinoma Intraductal Noninfiltrating Methotrexate Standardized mortality ratio Cisplatin business |
Zdroj: | International Journal of Radiation Oncology, Biology, Physics, 94, 5, pp. 1061-72 International Journal of Radiation Oncology Biology Physics, 94(5), 1061-1072. ELSEVIER SCIENCE INC Boekel, N B, Schaapveld, M, Gietema, J A, Russell, N S, Poortmans, P, Theuws, J C M, Schinagl, D A X, Rietveld, D H F, Versteegh, M I M, Visser, O, Rutgers, E J T, Aleman, B M P & van Leeuwen, F E 2016, ' Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors ', International journal of radiation oncology, biology, physics, vol. 94, no. 5, pp. 1061-72 . https://doi.org/10.1016/j.ijrobp.2015.11.040 International Journal of Radiation Oncology, Biology, Physics, 94, 1061-72 International Journal of Radiation Oncology-Biology-Physics, 94(5), 1061-1072 International journal of radiation oncology, biology, physics, 94(5), 1061-72. Elsevier Inc. |
ISSN: | 0360-3016 |
DOI: | 10.1016/j.ijrobp.2015.11.040 |
Popis: | Item does not contain fulltext PURPOSE: To conduct a large, population-based study on cardiovascular disease (CVD) in breast cancer (BC) survivors treated in 1989 or later. METHODS AND MATERIALS: A large, population-based cohort comprising 70,230 surgically treated stage I to III BC patients diagnosed before age 75 years between 1989 and 2005 was linked with population-based registries for CVD. Cardiovascular disease risks were compared with the general population, and within the cohort using competing risk analyses. RESULTS: Compared with the general Dutch population, BC patients had a slightly lower CVD mortality risk (standardized mortality ratio 0.92, 95% confidence interval [CI] 0.88-0.97). Only death due to valvular heart disease was more frequent (standardized mortality ratio 1.28, 95% CI 1.08-1.52). Left-sided radiation therapy after mastectomy increased the risk of any cardiovascular event compared with both surgery alone (subdistribution hazard ratio (sHR) 1.23, 95% CI 1.11-1.36) and right-sided radiation therapy (sHR 1.19, 95% CI 1.04-1.36). Radiation-associated risks were found for not only ischemic heart disease, but also for valvular heart disease and congestive heart failure (CHF). Risks were more pronounced in patients aged /=1997 (ie, anthracyline-based chemotherapy) increased the risk of CHF (sHR 1.35, 95% CI 1.00-1.83). CONCLUSION: Radiation therapy regimens used in BC treatment between 1989 and 2005 increased the risk of CVD, and anthracycline-based chemotherapy regimens increased the risk of CHF. |
Databáze: | OpenAIRE |
Externí odkaz: |